Skip to Main Content

Paper Details

Early Changes in Serum Albumin Predict Clinical and Endoscopic Outcomes in Patients With Ulcerative Colitis Starting Anti-TNF Treatment.
Inflamm Bowel Dis
10
2021
C-reactive protein, Patients, Serum Albumin, TNF, UC, Ulcerative Colitis, adalimumab, albumin, anti-TNF, infliximab, patient, patients, serum, tumor necrosis factor, ulcerative colitis
Author NameAffiliation
Sun-Ho LeeAsan Medical Center, University of Ulsan College of Medicine
Sun-Ho LeeMount Sinai Hospital, University of Toronto
Mark S SilverbergMount Sinai Hospital, University of Toronto
  • 1 - 3

Datasets

Release 1.2